22nd Century Group, Inc. (XXII): $4.50

-0.01 (-0.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add XXII to Watchlist
Sign Up

Industry: Biotech


Ranked

of 486

in industry

22nd Century Group Inc (XXII) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering XXII.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $4 $4 $4 $4.52 -11.5%

Price Target Last Issued July 17, 2020

XXII Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • XXII has a higher number of analysts covering the stock than nearly none of all US stocks.
  • XXII has a lower variance in analysts' estimates than nearly 100% of all US stocks.
  • XXII has a higher average analyst price target than nearly none of Tobacco Products stocks.
  • The upside potential (average analyst target price relative to current price) of XXII is greater than 6.01% of Healthcare stocks.

Make investment decisions regarding XXII using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9744 seconds.